- Public Comps
- Meds Apotek
Meds Apotek Valuation Multiples
Discover revenue and EBITDA valuation multiples for Meds Apotek and similar public comparables like Upexi, YES24, CarParts.com, LightInTheBox and more.
Meds Apotek Overview
About Meds Apotek
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Swedish Medicines Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty, skin care, and animal medicines.
Founded
2017
HQ

Employees
N/A
Website
Financials (FY)
EV
$48M
Valuation Multiples
Start free trialMeds Apotek Financials
Meds Apotek reported last fiscal year revenue of $105M and EBITDA of $2M.
In the same fiscal year, Meds Apotek generated $29M in gross profit, $2M in EBITDA, and $807K in net income.
Meds Apotek P&L
In the most recent fiscal year, Meds Apotek reported revenue of $105M and EBITDA of $2M.
Meds Apotek is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Meds Apotek Stock Performance
Meds Apotek has current market cap of $55M, and enterprise value of $48M.
Meds Apotek's stock price is $2.94.
Meds Apotek has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $48M | $55M | -0.6% | - | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMeds Apotek Valuation Multiples
Meds Apotek trades at 0.5x EV/Revenue multiple, and 25.2x EV/EBITDA.
Meds Apotek Financial Valuation Multiples
As of August 14, 2026, Meds Apotek has market cap of $55M and EV of $48M.
Meds Apotek has a P/E ratio of 67.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Meds Apotek Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Meds Apotek Margins & Growth Rates
In the most recent fiscal year, Meds Apotek reported gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.
Meds Apotek Margins
Meds Apotek Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Meds Apotek Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Meds Apotek Competitors
Meds Apotek competitors include Upexi, YES24, CarParts.com, LightInTheBox, KT Millie Seojae, Auto.de, d1000, Talea Group, Sportsman's Warehouse and Waqoo.
Most Meds Apotek public comparables operate across Pharmacies, Consumer E-commerce and Vertical E-commerce.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 18.6x | 11.1x | (24.3x) | - | |||
| 0.3x | - | 137.9x | - | |||
| 0.1x | 0.1x | (2.3x) | (15.2x) | |||
| 0.2x | 0.2x | 4.9x | 4.1x | |||
| 0.1x | - | 0.5x | - | |||
| - | - | 440.6x | - | |||
| 0.3x | - | 3.9x | - | |||
| 0.6x | - | 24.4x | - | |||
This data is available for Pro users. Sign up to see all Meds Apotek competitors and their valuation data. Start Free Trial | ||||||
Meds Apotek VC Funding History
Before going public, Meds Apotek raised $26M in total equity funding, across 4 rounds.
Meds Apotek Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Meds Apotek
| When was Meds Apotek founded? | Meds Apotek was founded in 2017. |
| Where is Meds Apotek headquartered? | Meds Apotek is headquartered in Sweden. |
| Is Meds Apotek publicly listed? | Yes, Meds Apotek is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Meds Apotek? | Meds Apotek trades under MEDS ticker. |
| When did Meds Apotek go public? | Meds Apotek went public in 2022. |
| Who are competitors of Meds Apotek? | Meds Apotek main competitors include Upexi, YES24, CarParts.com, LightInTheBox, KT Millie Seojae, Auto.de, d1000, Talea Group, Sportsman's Warehouse, Waqoo. |
| What is the current market cap of Meds Apotek? | Meds Apotek's current market cap is $55M. |
| What is the current revenue of Meds Apotek? | Meds Apotek's last fiscal year revenue is $105M. |
| What is the current EV/Revenue multiple of Meds Apotek? | Current revenue multiple of Meds Apotek is 0.5x. |
| Is Meds Apotek profitable? | No, Meds Apotek is not profitable. |
| How many companies Meds Apotek has acquired to date? | Meds Apotek hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Meds Apotek has invested to date? | Meds Apotek hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Meds Apotek
Lists including Meds Apotek
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




